Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Braz. j. biol ; 83: e249422, 2023. tab
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1339393

RESUMO

Abstract Ninety days study was conducted in hapas installed in earthen ponds. Fish of an average initial weight (220g) were evenly distributed in triplicate groups within fifteen hapas. Five experimental diets labeled as T1 (25% CP and NRC recommended amino acid level) as control diet, T2 (with 2% low protein and 5% amino acid supplementation), T3 (with 2% low protein and 10% amino acid supplementation), T4 (with 4% low protein and 10% amino acid supplementation) and T5 (with 4% low protein and 20% amino acid supplementation) were prepared. Fish were fed with @3% of their body weight twice a day at 10.00 & 16:00 hour. Significantly higher percent weight gain (420.18 ± 66.84a) and specific growth rate (13499.33±1273.54a) along with improved feed conversion ratio (1.29 ± 0.09b) and hundred percent survivals were recorded during the trial. Furthermore proximate analysis of meat showed significant improvement in the crude protein level (81.77 ± 0.19a) served with diet containing 20% limiting amino acids mixture. Therefore, limiting amino acids can be a source of cost effective feed and use safely in L. rohita diet.


Resumo O estudo de 90 dias foi realizado em hapas instalados em tanques de terra. Peixes com peso inicial médio (220 g) foram distribuídos uniformemente em grupos triplicados em 15 hapas. Cinco dietas experimentais rotuladas como T1 (25% de CP e NRC recomendado nível de aminoácidos) como dieta controle, T2 (com 2% de proteína baixa e 5% de suplementação de aminoácidos), T3 (com 2% de proteína baixa e 10% de suplementação de aminoácidos), T4 (com 4% de baixa proteína e 10% de suplementação de aminoácidos) e T5 (com 4% de baixa proteína e 20% de suplementação de aminoácidos) foram preparadas. Os peixes foram alimentados com 3% do seu peso corporal duas vezes por dia às 10h00 e 16h00. Ganho de peso significativamente maior (420,18 ± 66,84a) e taxa de crescimento específico (13499,33 ± 1273,54a) juntamente com taxa de conversão alimentar melhorada (1, 29 ± 0,09b) e sobrevivência de cem por cento foram registrados durante o ensaio. Além disso, a análise aproximada da carne mostrou melhora significativa no nível de proteína bruta (81,77 ± 0,19a) servida com dieta contendo 20% de mistura de aminoácidos limitantes. Portanto, a limitação de aminoácidos pode ser uma fonte de alimentação econômica e usada com segurança na dieta de L. rohita.


Assuntos
Animais , Cyprinidae , Ração Animal/análise , Suplementos Nutricionais , Dieta/veterinária , Aminoácidos
2.
Braz. j. biol ; 83: 1-8, 2023. tab
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1468928

RESUMO

Ninety days study was conducted in hapas installed in earthen ponds. Fish of an average initial weight (220g) were evenly distributed in triplicate groups within fifteen hapas. Five experimental diets labeled as T1 (25% CP and NRC recommended amino acid level) as control diet, T2 (with 2% low protein and 5% amino acid supplementation), T3 (with 2% low protein and 10% amino acid supplementation), T4 (with 4% low protein and 10% amino acid supplementation) and T5 (with 4% low protein and 20% amino acid supplementation) were prepared. Fish were fed with @3% of their body weight twice a day at 10.00 & 16:00 hour. Significantly higher percent weight gain (420.18 ± 66.84a) and specific growth rate (13499.33±1273.54a) along with improved feed conversion ratio (1.29 ± 0.09b) and hundred percent survivals were recorded during the trial. Furthermore proximate analysis of meat showed significant improvement in the crude protein level (81.77 ± 0.19a) served with diet containing 20% limiting amino acids mixture. Therefore, limiting amino acids can be a source of cost effective feed and use safely in L. rohita diet.


O estudo de 90 dias foi realizado em hapas instalados em tanques de terra. Peixes com peso inicial médio (220 g) foram distribuídos uniformemente em grupos triplicados em 15 hapas. Cinco dietas experimentais rotuladas como T1 (25% de CP e NRC recomendado nível de aminoácidos) como dieta controle, T2 (com 2% de proteína baixa e 5% de suplementação de aminoácidos), T3 (com 2% de proteína baixa e 10% de suplementação de aminoácidos), T4 (com 4% de baixa proteína e 10% de suplementação de aminoácidos) e T5 (com 4% de baixa proteína e 20% de suplementação de aminoácidos) foram preparadas. Os peixes foram alimentados com 3% do seu peso corporal duas vezes por dia às 10h00 e 16h00. Ganho de peso significativamente maior (420,18 ± 66,84a) e taxa de crescimento específico (13499,33 ± 1273,54a) juntamente com taxa de conversão alimentar melhorada (1, 29 ± 0,09b) e sobrevivência de cem por cento foram registrados durante o ensaio. Além disso, a análise aproximada da carne mostrou melhora significativa no nível de proteína bruta (81,77 ± 0,19a) servida com dieta contendo 20% de mistura de aminoácidos limitantes. Portanto, a limitação de aminoácidos pode ser uma fonte de alimentação econômica e usada com segurança na dieta de L. rohita.


Assuntos
Animais , Cyprinidae/crescimento & desenvolvimento , Cyprinidae/metabolismo , Dieta com Restrição de Proteínas/veterinária , Dietoterapia/veterinária
3.
Braz. j. biol ; 832023.
Artigo em Inglês | LILACS-Express | LILACS, VETINDEX | ID: biblio-1469144

RESUMO

Abstract Ninety days study was conducted in hapas installed in earthen ponds. Fish of an average initial weight (220g) were evenly distributed in triplicate groups within fifteen hapas. Five experimental diets labeled as T1 (25% CP and NRC recommended amino acid level) as control diet, T2 (with 2% low protein and 5% amino acid supplementation), T3 (with 2% low protein and 10% amino acid supplementation), T4 (with 4% low protein and 10% amino acid supplementation) and T5 (with 4% low protein and 20% amino acid supplementation) were prepared. Fish were fed with @3% of their body weight twice a day at 10.00 & 16:00 hour. Significantly higher percent weight gain (420.18 ± 66.84a) and specific growth rate (13499.33±1273.54a) along with improved feed conversion ratio (1.29 ± 0.09b) and hundred percent survivals were recorded during the trial. Furthermore proximate analysis of meat showed significant improvement in the crude protein level (81.77 ± 0.19a) served with diet containing 20% limiting amino acids mixture. Therefore, limiting amino acids can be a source of cost effective feed and use safely in L. rohita diet.


Resumo O estudo de 90 dias foi realizado em hapas instalados em tanques de terra. Peixes com peso inicial médio (220 g) foram distribuídos uniformemente em grupos triplicados em 15 hapas. Cinco dietas experimentais rotuladas como T1 (25% de CP e NRC recomendado nível de aminoácidos) como dieta controle, T2 (com 2% de proteína baixa e 5% de suplementação de aminoácidos), T3 (com 2% de proteína baixa e 10% de suplementação de aminoácidos), T4 (com 4% de baixa proteína e 10% de suplementação de aminoácidos) e T5 (com 4% de baixa proteína e 20% de suplementação de aminoácidos) foram preparadas. Os peixes foram alimentados com 3% do seu peso corporal duas vezes por dia às 10h00 e 16h00. Ganho de peso significativamente maior (420,18 ± 66,84a) e taxa de crescimento específico (13499,33 ± 1273,54a) juntamente com taxa de conversão alimentar melhorada (1, 29 ± 0,09b) e sobrevivência de cem por cento foram registrados durante o ensaio. Além disso, a análise aproximada da carne mostrou melhora significativa no nível de proteína bruta (81,77 ± 0,19a) servida com dieta contendo 20% de mistura de aminoácidos limitantes. Portanto, a limitação de aminoácidos pode ser uma fonte de alimentação econômica e usada com segurança na dieta de L. rohita.

4.
J Family Med Prim Care ; 10(6): 2376-2380, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-34322441

RESUMO

INTRODUCTION: HBV is major health problem globally due to complications, including ACLF, cirrhosis and hepa¬tocellular carcinoma. ACLF due to exacerbation of CHB is associate with 30%-70% mortality. Reduction of HBV-DNA is therefore a target of therapy in ACLF-B. METHODS: Patients with spontaneous reactivation of HBV [(ALT >5×ULN or >2× baseline) and HBV-DNA >20,000 IU/ml] were randomized to Tenofovir mono therapy (300 mg/day) or Tenofovir plus Telbivudine (600 mg/day) dual therapy with standard care. Clinical and biochemical parameters were evaluated at baseline, 1 week, 4 weeks and at 3 months. Virological evaluation was done at baseline and at 3 months. Primary end points were reduction of HBV-DNA and resolution of ascites, as applied. Secondary end point was reduction of liver related complications, therapy related adverse effects and survival at 3 months. RESULTS: 27 patients were enrolled. 15 received mono therapy with Tenofovir and 12 received dual therapy (Tenofovir plus Telbivudine). Baseline parameters in 2 groups had no significant difference. In both groups there was significant improvement of S. bilirubin, ALT, INR, CTP score and MELD score. Only MELD score showed significant improvement in patient with dual therapy at 3 months in comparison to mono therapy. 11 patients on Tenofovir mono therapy (n=15) showed undetected HBV-DNA (91.7%) at 3 months and one patient had detectable HBV-DNA (<2,000 IU/ml). 10 patients on dual therapy (n=12) had undetectable HBV-DNA (100%). Ascites resolved in 3 patients in both groups. Patients receiving dual therapy showed significant improvement in AKI on follow up compared to those on Tenofovir mono therapy. Among 5 deaths, 3 received mono therapy with Tenofovir and 2 dual therapy. Predictors of mortality had high S. bilirubin, HBV-DNA, MELD score and CTP score. CONCLUSION: In spontaneous reactivation of HBV presenting as ACLF, combination of Telbivudine plus Tenofovir is safer with less nephrotoxicity and better outcomes.

5.
Ann R Coll Surg Engl ; 103(2): 104-109, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33185459

RESUMO

INTRODUCTION: There has been guidance from the government and orthopaedic community on how best to ensure the safety of our patients and colleagues as we recommence elective surgery in the UK. The primary aim was to determine what proportion of patients feel they should proceed with their elective hip and knee arthroplasty surgery during the COVID-19 climate. The secondary aim was to investigate what variables affected this decision. METHODS: Patient information from a single surgeon's waiting list in a district general hospital were recorded. A standardised telephone discussion was had with all the patients noting the severity of pain and the potential reasons for not wanting to proceed with surgery. RESULTS: A total of 70.6% (96/136) of patients wished to proceed with surgery; 29.4% (40/136) did not wish to proceed. The decision to proceed with surgery was not correlated with sex, American Society of Anesthesiologists grade or COVID-19 risk. Those who wished to proceed with surgery had a mean age of 68.5 years while those who did not had a mean age of 72.4 years (P = 0.03). Within the matched subgroups, patients under the age of 70 years were more willing to proceed with primary hip arthroplasty surgery (87.9%) compared with primary knee arthroplasty surgery (57.1%; P = 0.007); 75% of the patients who did not wish to proceed with surgery expressed concerns about perioperative COVID-19 infection. CONCLUSION: There is a significant proportion of arthroplasty patients on waiting lists who would be willing to accept the increased risks associated with COVID-19 to undergo surgery on an urgent basis. The subgroup of younger patients awaiting hip arthroplasty is more willing than those awaiting knee arthroplasty to proceed with surgery.


Assuntos
Artroplastia de Quadril , Artroplastia do Joelho , Atitude Frente a Saúde , COVID-19 , Infecção Hospitalar , Osteoartrite do Quadril/cirurgia , Osteoartrite do Joelho/cirurgia , Preferência do Paciente , Idoso , Procedimentos Cirúrgicos Eletivos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Risco , SARS-CoV-2 , Listas de Espera
6.
Iran J Vet Res ; 21(2): 92-96, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32849886

RESUMO

BACKGROUND: Analgesic and hemodynamic effects of ketamine in subanesthetic doses during surgical anesthesia and postoperative, are due to the action on the N-methyl-D-aspartate receptors (NMDAR). AIMS: To evaluate the intraoperative cardiorespiratory effects provided by ketamine compared to lidocaine, both administered epidurally, in bitches submitted to ovariohysterectomy. METHODS: Thirty-six dogs of different breeds were used in a randomized, prospective, and blinded clinical trial. Two groups were formed: GKET (ketamine 3 mg/kg, n=18) and GLIDO (lidocaine 4 mg/kg, n=18). Animals were premedicated with acepromazine 0.05 mg/kg intravenous. Anesthesia was induced with propofol 5 mg/kg intravenous. Anesthetic maintenance was performed with isoflurane in 100% oxygen. Every 5 min during surgery, heart rate (HR), respiratory rate (RR), esophageal temperature (°C), oxygen saturation (SPO2), end tidal carbon dioxide (ETCO2) and mean arterial pressure (MAP) were monitored. RESULTS: Cardiorespiratory variables during anesthesia were within normal ranges. Heart rate was significantly higher at 5 (108 ± 12 vs 95 ± 11) and 10 (110 ± 11 vs 97 ± 11) min in GKET compared to GLIDO after the start of surgery (P=0.03 and P=0.01, respectively). Mean arterial pressure was higher in GKET, (100 ± 23, 105 ± 35, and 103 ± 35 mmHg) in comparison with GLIDO (66 ± 7, 74 ± 10, and 67 ± 9 mmHg) at 20, 25 and 30 min (P=0.01, P=0.004, and P=0.002, respectively). Mild hypothermia at 25 (36.5 1.3C) and 30 (36.5 1.4C) min in the GKET was recorded. CONCLUSION: Epidural administration of ketamine provides better hemodynamic stability, compared to the use of epidural lidocaine.

7.
J Dermatolog Treat ; 24(2): 101-6, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21756157

RESUMO

OBJECTIVE: The study aims to illustrate the range of lifetime risks of lymphoma, tuberculosis (TB), and demyelinating diseases with TNF-α inhibitors in psoriasis patients. METHODS: Previously published data and online resources were used to determine the risk of the TB, demyelinating disease, and lymphoma with and without TNF-α inhibitor treatment. Lifetime risks for heart disease and stroke were collected using a Medline search. All cancer, trauma, and environmental statistics were obtained from the data published by National Cancer Institute, National Safety Council, and the National Oceanic and Atmospheric Administration, respectively. RESULTS: The lifetime risks of TNF-α-inhibitor-linked conditions and comparators are as follows: TNF-α inhibitor-linked conditions: lymphoma with: without TNF-α inhibitors (0.5-4.8%:2.3%), TB with:without TNF-α inhibitors (0-17.1%:0.3%), and demyelinating disease with:without TNF-α inhibitors (0.1-1.7%:0.15%). Comparators: cancer (40.4%), heart disease (36.2%), stroke (18.4%), accidental death (3.0%), motor vehicle death (1.2%), and lightning strike (0.033%). LIMITATIONS: Much of the data on lifetime risks of disease with TNF-α inhibitor were for patients with rheumatoid arthritis and not psoriasis. CONCLUSIONS: The risks of lymphoma, demyelinating diseases, and tuberculosis with TNF-α inhibitors are lower than risks patients face on a regular basis. Screening reduces the risk of tuberculosis in patients receiving TNF-α inhibitors.


Assuntos
Antirreumáticos/efeitos adversos , Doenças Desmielinizantes/induzido quimicamente , Linfoma/induzido quimicamente , Tuberculose/induzido quimicamente , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Adalimumab , Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais Humanizados/efeitos adversos , Benchmarking , Etanercepte , Humanos , Imunoglobulina G/efeitos adversos , Infliximab , Psoríase/tratamento farmacológico , Receptores do Fator de Necrose Tumoral , Medição de Risco , Fatores de Risco
8.
Stud Health Technol Inform ; 172: 155-60, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22910516

RESUMO

UNLABELLED: Elementary schools in Jordan have included health education material in curricula to promote healthy lifestyles among younger school children. However, the relation between healthy lifestyles and the prevention of chronic diseases such as cancer has not been an explicit component in school curricula of younger age groups. We sought to explore the level of knowledge among 6th grade students as well as their attitudes with respect to cancer. This comes as part of a pilot project to develop an educational series on cancer prevention that aims to meet knowledge gaps specific to the community of students in this age group in Jordan. METHODS: A questionnaire composed of items measuring knowledge about cancer and cancer prevention through healthy practices, attitudes towards cancer, and intentions to engage in healthy behaviors was developed. Questionnaires previously used in similar age groups elsewhere were used as a reference. Our questionnaire was reviewed and approved by the Ministry of Education - School Health & Nutrition Department. Sixth graders in a convenience sample of four schools selected by the Ministry of Education completed the self-administered questionnaire. RESULTS: Ninety-six 6th graders from four schools answered the baseline survey, but 28% of the surveys were excluded from the analysis (data quality problems) leaving 69 student participants. In the original sample of 96 students, 48 (69.6%) were girls. Among the 69 student participants, 67 (97.1%) had heard of cancer, but fewer than 44 (63.8% knew it was not a contagious disease. Regarding fear, 29 (42%) would not play with a cancer patient. Concerning prevention of the most prevalent cancers in Jordan as research has shown that certain risk factors increase the chance that a person will develop cancer. The most common risk factors are smoking, Poor diet, lack of physical activity, or being overweight, 25 (36.2%) knew breast cancer was preventable, and 28 (40.6%) and 24 (34.8%) knew this regarding lung and colorectal cancers, respectively. About 40 (57.8%) students identified healthy dietary behaviors (e.g., low fat, low sugar), but only six could identify the ideal frequency for exercise (60 minutes daily). Fifty-eight (84.1%) agreed that cigarettes harmed the health. However, only 21 (30.4%) found it easy to avoid exposure to secondhand smoke. Nine (13%) reported smoking water pipes, but only one reported smoking cigarettes. Forty-eight (69.6%) and 47 (68.1%) agreed that daily physical activity and healthy eating were important, respectively. Fifty-two (75.4%) students found it easy to eat healthy at home, but only 37 (53.6%) found it easy to do so at school. Finally, 63 (91.3%) students wanted to learn more about cancer. CONCLUSION: Although a significant number of our sample of students has heard about cancer and students exhibit some knowledge regarding healthy practices, our results show that knowledge gaps exist with regard to the nature of cancer as a noncontagious disease, the preventability of specific cancers, and the link between specific risk factors and cancer.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Neoplasias/prevenção & controle , Medição de Risco , Assunção de Riscos , Criança , Feminino , Comportamentos Relacionados com a Saúde , Humanos , Jordânia , Masculino , Neoplasias/etiologia , Inquéritos e Questionários
9.
PLoS Negl Trop Dis ; 4(4): e652, 2010 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-20386601

RESUMO

BACKGROUND: Porcine cysticercosis is caused by a zoonotic tapeworm, Taenia solium, which causes serious disease syndromes in human. Effective control of the parasite requires knowledge on the burden and pattern of the infections in order to properly direct limited resources. The objective of this study was to establish the spatial distribution of porcine cysticercosis in Mbulu district, northern Tanzania, to guide control strategies. METHODOLOGY/PRINCIPAL FINDINGS: This study is a secondary analysis of data collected during the baseline and follow-up periods of a randomized community trial aiming at reducing the incidence rate of porcine cysticercosis through an educational program. At baseline, 784 randomly selected pig-keeping households located in 42 villages in 14 wards were included. Lingual examination of indigenous pigs aged 2-12 (median 8) months, one randomly selected from each household, were conducted. Data from the control group of the randomized trial that included 21 of the 42 villages were used for the incidence study. A total of 295 pig-keeping households were provided with sentinel pigs (one each) and reassessed for cysticercosis incidence once or twice for 2-9 (median 4) months using lingual examination and antigen ELISA. Prevalence of porcine cysticercosis was computed in Epi Info 3.5. The prevalence and incidence of porcine cysticercosis were mapped at household level using ArcView 3.2. K functions were computed in R software to assess general clustering of porcine cysticercosis. Spatial scan statistics were computed in SatScan to identify local clusters of the infection. The overall prevalence of porcine cysticercosis was 7.3% (95% CI: 5.6, 9.4; n = 784). The K functions revealed a significant overall clustering of porcine cysticercosis incidence for all distances between 600 m and 5 km from a randomly chosen case household based on Ag-ELISA. Lingual examination revealed clustering from 650 m to 6 km and between 7.5 and 10 km. The prevalence study did not reveal any significant clustering by this method. Spatial scan statistics found one significant cluster of porcine cysticercosis prevalence (P = 0.0036; n = 370). In addition, the analysis found one large cluster of porcine cysticercosis incidence based on Ag-ELISA (P = 0.0010; n = 236) and two relatively small clusters of incidence based on lingual examination (P = 0.0012 and P = 0.0026; n = 241). These clusters had similar spatial location and included six wards, four of which were identified as high risk areas of porcine cysticercosis. CONCLUSION/SIGNIFICANCE: This study has identified local clusters of porcine cysticercosis in Mbulu district, northern Tanzania, where limited resources for control of T. solium could be directed. Further studies are needed to establish causes of clustering to institute appropriate interventions.


Assuntos
Cisticercose/veterinária , Doenças dos Suínos/epidemiologia , Doenças dos Suínos/prevenção & controle , Taenia solium/isolamento & purificação , Animais , Antígenos de Helmintos/análise , Análise por Conglomerados , Cisticercose/epidemiologia , Cisticercose/prevenção & controle , Ensaio de Imunoadsorção Enzimática , Características da Família , Humanos , Incidência , Prevalência , Suínos , Doenças dos Suínos/parasitologia , Tanzânia/epidemiologia , Língua/parasitologia , Zoonoses/epidemiologia , Zoonoses/parasitologia
11.
Acta Trop ; 87(1): 95-101, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12781383

RESUMO

Mitochondrial DNA sequences of Taenia solium have fully been analyzed. Analysis of the full length of cytochrome c oxidase subunit 1 (1620 bp) and cytochrome b (1068 bp) genes of T. solium, isolated from Asia (China, Thailand, Indonesia and India), from Latin America (Mexico, Ecuador, Bolivia, Peru and Brazil) and from Africa (Tanzania, Mozambique and Cameroon), has revealed that the two phylogenies obtained were similar to each other regardless of the genes examined. The isolates from Asia formed a single cluster, whereas those from Latin America combined with those from Africa to form an additional cluster. It was estimated that these two genotypes emerged approximately 4-8 x 10(5) years ago. These results together with recent study of the ancient of human taeniid cestodes emerged several MYA in Africa, historical data on swine domestication, distribution of pigs and colonization patterns suggest that T. solium was introduced recently into Latin America and Africa from different regions of Europe during the colonial age, which started 500 years ago, and that T. solium of another origin independently spread in Asian countries, perhaps from China. Why did not T. solium of European origin invade or spread into Asia during the colonial age? Analysis of T. solium distribution must include other Taenia species, especially T. saginata and T. asiatica, which can not be differentiated from each other morphologically. BESS T-base analysis for differentiation of all human Taenia species including the two genotypes of T. solium, and T. saginata and T. asiatica has also been characterized. BESS T-base analysis differentiates African isolates from Latin American isolates as well but more samples should be analyzed for obtaining conclusive evidence for the latter. Serological analysis of cyst fluid of T. solium cysticerci obtained in China and Indonesia and from Mozambique and Ecuador indicates geographical differences in their banding patterns. These differences are discussed in the light of possible differences in pathology of T. solium worldwide. As it has been speculated that the ancient T. solium emerged several million years ago in Africa, it is necessary to analyze more isolates from Africa. Such working hypothesis may be evaluated combined with symptomatology and serology when we get additional DNA data from such areas, since there are some varieties of manifestation of neurocysticercosis with or without subcutaneous cysticercosis and of antigens of cyst fluid of T. solium from Asia and from Africa and/or America. Transfer of techniques of molecular identification and sero- and immuno-diagnoses between researchers and technicians from endemic countries using their own materials should be promoted with the aim of better international cooperation for the control of cysticercosis.


Assuntos
Taenia solium/genética , Teníase/parasitologia , Animais , Carnívoros/parasitologia , Bovinos , Cysticercus/imunologia , Cistos/imunologia , Variação Genética , Genótipo , Humanos , Sus scrofa , Doenças dos Suínos/parasitologia , Taenia solium/isolamento & purificação , Teníase/diagnóstico , Teníase/prevenção & controle , Teníase/terapia
12.
J Mol Cell Cardiol ; 33(11): 2037-46, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11708847

RESUMO

Nitric oxide (NO) has been implicated in the "second-window" of ischemic preconditioning (PC). However, the identity of the end effector after initiation of preconditioning by NO is not known. It is likely that NO is involved in opening of mitochondrial ATP-sensitive potassium (mitoK(ATP)) channels. We hypothesized that NO is an important trigger for the opening of mitoK(ATP) channels in the late phase of preconditioning and inducible nitric oxide synthase (iNOS) up-regulation via NF kappa B plays a critical role in diazoxide-induced cardioprotection. To examine this, diazoxide (7 mg/kg) was administered to wild-type (WT) mice and mice lacking the gene 24 hours before 40 minutes of global ischemia. Hearts were perfused in a Langendorff mode and effects of activation of mitoK(ATP) channel and other interventions on functional, biochemical and pathological changes in ischemic hearts were assessed. In hearts from WT mice treated diazoxide, left-ventricular-developed pressure, end-diastolic pressure and coronary flow were significantly improved after ischemia/reperfusion (I/R); lactate dehydrogenase (LDH) release was also significantly decreased, while ATP contents were significantly higher. Administration of 5-HD, a specific blocker of mitoK(ATP) channel or l -NAME, an inhibitor of iNOS before I/R, during diazoxide-pretreatment completely blocked the late cardioprotection against ischemia. Late cardioprotection was also blocked by inhibition of either PKC- delta by rottlerin or NF kappa B by DDTC before diazoxide pretreatment. Diazoxide pretreatment significantly increased nuclear translocation of p65 which was blocked by protein kinase C (PKC) or nitric oxide synthase (NOS) inhibition. Diazoxide was totally inefffective in iNOS knockout mice. These results suggest that diazoxide activates NF kappa B via PKC signaling pathway and that leads to iNOS up-regulation after 24 hours. NO which is generated upon ischemic stress triggers the opening of mitoK(ATP)channel as an end effector of cardioprotection during late PC.


Assuntos
Precondicionamento Isquêmico Miocárdico , Mitocôndrias/metabolismo , Óxido Nítrico/fisiologia , Canais de Potássio/metabolismo , Acetofenonas/farmacologia , Transporte Ativo do Núcleo Celular , Trifosfato de Adenosina/metabolismo , Animais , Antiarrítmicos/farmacologia , Benzopiranos/farmacologia , Velocidade do Fluxo Sanguíneo , Pressão Sanguínea , Núcleo Celular/metabolismo , Ácidos Decanoicos/farmacologia , Diazóxido/farmacologia , Inibidores Enzimáticos/farmacologia , Ventrículos do Coração/metabolismo , Hidroxiácidos/farmacologia , Isquemia/metabolismo , Isoenzimas/farmacologia , L-Lactato Desidrogenase/metabolismo , Camundongos , Camundongos Knockout , NF-kappa B/metabolismo , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Bloqueadores dos Canais de Potássio/farmacologia , Proteína Quinase C/metabolismo , Proteína Quinase C/farmacologia , Proteína Quinase C-delta , Traumatismo por Reperfusão , Transdução de Sinais , Fatores de Tempo , Fator de Transcrição RelA , Regulação para Cima
13.
Circulation ; 104(1): 85-90, 2001 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-11435343

RESUMO

BACKGROUND: The mitochondrial K(ATP) (mitoK(ATP)) channel has been shown to confer short- and long-term cardioprotection against prolonged ischemia via protein kinase C (PKC) signaling pathways. However, the exact association between PKC or its isoforms and mitoK(ATP) channels has not yet been clarified. The present study tested the hypothesis that the activity and translocation of PKC to the mitochondria are important for cardiac protection elicited by mitoK(ATP) channels. Methods and Results-PKC was downregulated by prolonged (24-hour) treatment with phorbol 12-myristate 13-acetate (4 microgram/kg body weight) before subsequent experiments in rats. Langendorff-perfused rat hearts were subjected to 40 minutes of ischemia followed by 30 minutes of reperfusion. Effects of PKC downregulation on the activation of mitoK(ATP) channels and other interventions on hemodynamic, biochemical, and pathological changes were assessed. Subcellular localization of PKC isoforms by Western blot analysis and immunocytochemistry demonstrated that PKC-alpha and PKC-delta were translocated to the sarcolemma and that PKC-delta was translocated to the mitochondria after diazoxide treatment. In hearts treated with diazoxide (80 micromol/L), a significant improvement in cardiac function and an attenuation of cell injury were observed. In PKC-downregulated hearts, protection was abolished because mitoK(ATP) channels could not be activated by diazoxide. CONCLUSIONS: These data suggest that PKC activation is required for the opening of mitoK(ATP) channels during protection against ischemia and that this effect is linked to isoform-specific translocation of PKC-delta to the mitochondria.


Assuntos
Diazóxido/farmacologia , Regulação para Baixo/efeitos dos fármacos , Mitocôndrias/metabolismo , Bloqueadores dos Canais de Potássio , Canais de Potássio/metabolismo , Proteína Quinase C/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Relação Dose-Resposta a Droga , Imuno-Histoquímica , Técnicas In Vitro , Precondicionamento Isquêmico Miocárdico/métodos , Isoenzimas/metabolismo , L-Lactato Desidrogenase/metabolismo , Masculino , Isquemia Miocárdica/metabolismo , Miocárdio/citologia , Miocárdio/enzimologia , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/fisiologia , Ratos , Ratos Sprague-Dawley , Traumatismo por Reperfusão/metabolismo , Sarcolema/metabolismo , Frações Subcelulares/enzimologia , Acetato de Tetradecanoilforbol/farmacologia , Função Ventricular Esquerda/efeitos dos fármacos
14.
Rev. argent. micol ; 20(1/3): 34-9, 1997. ilus
Artigo em Espanhol | LILACS | ID: lil-216237

RESUMO

Se presentan los datos clínicos, microbiológicos y terapéuticos de un paciente que presentó una micosis doble en el miembro superior izquierdo. Era un enfermo de 49 años de edad, de sexo masculino, que había recibido un trasplante de riñón cadavérico y fue internado en el Hospital Argerich de Buenos Aires con lesiones inflamatorias seudotumorales ubicadas en el hombro y en la muñeca del brazo izquierdo. Había sufrido una insuficiencia renal crónica compensada con hemodiálisis y en julio de 1993 se le efectuó un trasplante de riñón cadavérico. Se le administró un tratamiento inmunodepresor que incluía metilprednisona, ciclosporina y azatioprina. Presentó dos episodios de rechazo agudo del trasplante que fueron controlados con altas dosis de corticosteriodes por vía intravenosa. En 1993 se le detectó una diabetes que fue tratada con glibenclamida. El paciente vivía en el Gran Buenos Aires en una casa de madera, sin instalaciones sanitarias adecuadas. Trabajaba como jardinero y cultivando vegetales, en ambas tareas manejaba abonos. No había tenido antecedentes de infecciones previas y había abandonado el control médico varios meses antes de su internación. En el momento de su ingreso se comprobaron una lesión abscedada en el hombro izquierdo, una placa con grandes nódulos en la muñeca izquierda y un nódulo aislado en el ángulo del maxilar inferior derecho. Se llevaron a cabo punciones aspirativas, drenajes quirúrgicos y resecciones de los cuales se obtuvieron muestras para los exámenes histopatológicos y microbiológicos. Los estudios microbiológicos acusaron: 1) en el hombro izquierdo hifas hialinas anchas no septadas y desarrollo de un hongo del género Mucor; 2) de la lesión de la muñeca izquierda hifas septadas, estrechas y pardas y desarrollo de un hongo dermatiáceo que no pudo ser clasificado por no presentar fructificación y 3) del nódulo del maxilar se obtuvo el desarrollo de Streptococcus viridans y Porphyromonas sp. Las infecciones micóticas fueron tratadas exitosamente con anfotericina B acompañada de drenaje quirúrgico y resección. La infección bacteriana se controló con amoxicilina/ácido clavulánico. Se efectuó un tratamiento supresivo con itraconazol para evitar la recaída de la feohifomicosis durante 6 meses y se prosiguió el control del paciente durante 1 año, sin haber presentado recaídas


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Mucormicose/diagnóstico , Mucor/isolamento & purificação , Micoses/diagnóstico , Transplante de Rim/efeitos adversos , Anfotericina B/uso terapêutico , Hospedeiro Imunocomprometido , Insuficiência Renal Crônica/complicações , Itraconazol/uso terapêutico , Infecções Oportunistas/etiologia
15.
Acta Eur Fertil ; 25(5): 299-301, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7660718

RESUMO

Septate uterus is the intracavitary pathology which is most associated with infertility and/or preterm labor; therefore, it is primary indication for hysteroscopic metroplasty. By the introductio of the resectoscope in gynaecological endoscopy the surgical technique has been revolutioned. GnRHa therapy before surgery has showed some advantages related to surgical results, surgery time, intraoperative bleeding and endometrial detachment, and amount of fluids used for uterine cavity distention. The treatment before hysteroscopic metroplasty for partial septus has not influenced positive results, while for uterine septus that reached the inferior third of the cavity or moreover, it provided better condition for this procedure.


Assuntos
Histeroscopia/métodos , Cuidados Pré-Operatórios , Pamoato de Triptorrelina/uso terapêutico , Útero/cirurgia , Feminino , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Fatores de Tempo , Doenças Uterinas/cirurgia , Hemorragia Uterina/prevenção & controle , Útero/anormalidades
16.
Am J Gastroenterol ; 88(6): 958-61, 1993 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8389095

RESUMO

A 35-yr-old male presented with a 3-yr history of voluminous watery diarrhea. He had episodes of severe generalized weakness which responded to fluid and electrolyte replacement therapy. Investigations revealed a solitary liver mass and an elevated vasoactive intestinal polypeptide level. An extensive work-up did not show any other extrahepatic primary lesion. Surgical resection ameliorated all of his symptoms, accompanied by a decrease in the vasoactive intestinal polypeptide level. We believe that this patient represents a case of primary hepatic vipoma syndrome. To our present knowledge, this has not been reported previously. We discuss the clinical manifestations, investigations, and management of the case.


Assuntos
Neoplasias Hepáticas/epidemiologia , Vipoma/epidemiologia , Adulto , Biópsia , Terapia Combinada , Embolização Terapêutica , Hepatectomia , Humanos , Fígado/patologia , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/terapia , Masculino , Octreotida/uso terapêutico , Peptídeo Intestinal Vasoativo/metabolismo , Vipoma/patologia , Vipoma/terapia
17.
J. bras. ginecol ; 94(8): 353-6, 1984.
Artigo em Português | LILACS | ID: lil-22842

RESUMO

Neste estudo avaliou-se a acao terapeutica de ketoconazole por via sistemica em 105 pacientes com candidiase vulvovaginal, nas formas aguda e cronica. O ketoconazole foi administrado na dose de dois comprimidos de 200 mg por dia, durante cinco dias consecutivos. Realizou-se exame micologico a fresco (microscopia) e cultura em meio de Nickerson, antes do tratamento (para confirmacao diagnostica) e sete e trinta dias apos o termino do mesmo (para comprovacao da cura). Foi observado um percentual de cura micologica da ordem de 75,5%. Ocorreram efeitos colaterais em 19 pacientes (18,1%), tornando necessaria a interrupcao do tratamento em tres pacientes, sendo em um caso por cefaleia, vomitos e astenia moderados, e em dois casos por nausea e mal-estar tambem de grau moderado. Os investigadores consideraram o tratamento da candidiase vulvovaginal entre bom e excelente em 78,4% dos casos, enquanto que para as pacientes tal conceito situou-se em 81,2% dos casos


Assuntos
Humanos , Candidíase Vulvovaginal , Cetoconazol
18.
JAMA ; 246(9): 970-3, 1981 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-7253181

RESUMO

A neurological syndrome characterized by episodes of confusion, slurred speech, and unsteadiness is described in patients who have undergone jejunoileostomy for obesity. This syndrome has been noted in seven of 110 patients studied, although it may be more common. It appears to subside spontaneously or may respond to oral food restriction, with or without intravenous fluid plus vitamins and minerals. Episodes tend to recur in a given patient. Reversible changes in the EEG have been observed. Pertinent clinical and laboratory findings are described but no definite etiologic factor has been identified. The possible mechanisms involved in this syndrome of metabolic encephalopathy following jejunoileostomy are discussed.


Assuntos
Encefalopatias/etiologia , Íleo/cirurgia , Jejuno/cirurgia , Obesidade/terapia , Procedimentos Cirúrgicos Operatórios/efeitos adversos , Adulto , Bactérias/crescimento & desenvolvimento , Feminino , Humanos , Intestinos/microbiologia , Masculino , Pessoa de Meia-Idade , Distúrbios Nutricionais/etiologia , Desequilíbrio Hidroeletrolítico/etiologia
19.
Am J Obstet Gynecol ; 105(4): 525-8, 1969 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-5824869

RESUMO

PIP: The purpose of this study was to determine if large amounts of estrogenic hormones produced by the placenta could play a role in the development of the lymphoid tissue changes of pregnancy. 40 immature female rats were used. The group was divided into 4 lots of 10 animals each. The first group was castrated. The second group was castrated and given 1.5 mg of estradiol valerianate every fifth day to a total of 4.5 mg. The third group was castrated and injected with peanut oil only, the vehicle used for the estradiol. The fourth, a control group, was untreated. All animals were killed on Day 19. Spleens, genital organs, thymus glands, and mediastinal lumph nodes were removed, weighed and prepared for histologic examination. Thymus glands showed involution. The genital organs were well developed in the group receiving estradiol, but showed involution in other castrated animals. Histological examination of the thymus of animals receiving estradiol showed signs of lymphatic depletion. Spleens, lymph nodes, and adrenals appeared normal. It was concluded that estradiol, and possible other estrogenic hormones, might be of importance in the mechanisms of the immune response. This could apply to the Rh immunization of the pregnant female to her fetus.^ieng


Assuntos
Estradiol/farmacologia , Linfonodos/efeitos dos fármacos , Baço/efeitos dos fármacos , Timo/efeitos dos fármacos , Animais , Atrofia , Peso Corporal , Castração , Feminino , Tolerância Imunológica , Tamanho do Órgão , Gravidez , Ratos , Timo/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA